Quick Overview
- American Express delivers Q1 2026 results on April 23, with analysts projecting approximately 9.6% year-over-year expansion in earnings per share and revenue
- Billed business advanced 8% year-over-year in Q4 2025, though growth momentum has plateaued rather than accelerated
- Credit metrics continue performing well — charge-offs increased modestly while reserve additions are moderating
- Full-year 2026 outlook projects 9–10% revenue expansion with EPS ranging from $17.30 to $17.90, matching Street expectations
- Analyst consensus leans Moderate Buy, with average target price of $352.60 representing roughly 6.3% potential gain
American Express (AXP) approaches its Q1 2026 earnings announcement scheduled for April 23 with fundamentals intact — though that stability itself may present challenges for the stock.
The company’s operational metrics appear sound. Consumer spending shows resilience. Credit performance remains healthy. Yet for shares trading at a premium valuation, merely adequate results may fall short of what investors demand.
Analysts anticipate approximately 9.6% year-over-year advancement in both earnings per share and total revenue. The trajectory appears consistent, though lacking compelling momentum.
The central focus falls on billed business — the measurement of card member spending — which represents the primary metric driving AXP investor sentiment. This figure registered 8% year-over-year growth during Q4 2025, maintaining the pace established throughout fiscal 2025. After climbing from 6% in Q1 2025 to 7% in Q2, the growth rate has stabilized.
This pattern increasingly resembles a mature, predictable business model — a characterization that creates tension with the stock’s 21.4x trailing earnings valuation.
Credit Performance Remains Solid
The credit portfolio shows continued strength. Charge-offs reached $1.27 billion in Q4, rising from $1.13 billion during the same quarter one year prior, though the quarter-over-quarter progression remained measured.
Provisions moved higher to $1.41 billion compared with $1.28 billion in Q3. The reserve addition totaled just $141 million — declining from $222 million in Q2 2025. This pattern reflects prudent risk management rather than emerging stress.
Net interest income expanded 12% year-over-year, loan balances grew 7%, and interest margins widened. These indicators point toward credit expansion that balances profitability with discipline. The overall picture suggests ongoing normalization within historical parameters.
Cramer’s Perspective on Timing
Jim Cramer addressed AXP during a recent Mad Money broadcast, offering tactical guidance for prospective investors ahead of the earnings release.
“American Express almost always seems to retreat when we see the numbers and then runs a couple of days later,” Cramer said. His advice: wait until the end of earnings day — or the following morning — before buying, to avoid the “knee-jerk selling” that tends to follow even solid results.
Cramer has also pointed to AXP’s premium customer base as a structural positive. “Demand for premium products can stay strong even if the rest of the economy slows down,” he said in early April.
Bank of America’s Q1 report from April 15 provides relevant context for consumer spending patterns. Card transaction volume increased 6% year-over-year, with particular strength in travel, services, and retail categories. Given American Express’s affluent customer demographic, comparable or superior performance seems probable — establishing high single-digit billed business growth as a baseline expectation for Q1.
Shares currently trade around 18.5x forward earnings, representing approximately 20% compression from December peak levels. This valuation reset creates somewhat more favorable conditions for potential appreciation.
Management’s fiscal 2026 guidance anticipates 9–10% revenue growth alongside EPS of $17.30–$17.90 — translating to roughly 14% year-over-year earnings growth. Analyst estimates have remained largely stable following this guidance update.
Among the most recent 17 analyst ratings, seven recommend Buy, nine suggest Hold, and one advises Sell. The consensus price target stands at $352.60, indicating approximately 6.3% upside from present trading levels.
